Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases.
van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van der Sijp JR, van Gulik TM, Slooter GD, Klaase JM, Putter H, Tollenaar RA. van Duijnhoven FH, et al. Among authors: van hillegersberg r, van coevorden f, van gulik tm, van der sijp jr. Ann Surg Oncol. 2006 May;13(5):651-8. doi: 10.1245/ASO.2006.08.014. Epub 2006 Mar 17. Ann Surg Oncol. 2006. PMID: 16538411
An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer.
Gao Y, Ventura-Diaz S, Wang X, He M, Xu Z, Weir A, Zhou HY, Zhang T, van Duijnhoven FH, Han L, Li X, D'Angelo A, Longo V, Liu Z, Teuwen J, Kok M, Beets-Tan R, Horlings HM, Tan T, Mann R. Gao Y, et al. Among authors: van duijnhoven fh. Nat Commun. 2024 Nov 7;15(1):9613. doi: 10.1038/s41467-024-53450-8. Nat Commun. 2024. PMID: 39511143 Free PMC article.
The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy.
Gunster JLB, van Duijnhoven FH, Scholten AN, Smorenburg CH, Dezentje VO, van Olmen JP, Marijnen CAM, Stokkel MPM, Loo CE, Schrijver AM. Gunster JLB, et al. Among authors: van duijnhoven fh. Breast Cancer Res Treat. 2024 Sep 26. doi: 10.1007/s10549-024-07478-5. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39327358
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.
Nederlof I, Isaeva OI, de Graaf M, Gielen RCAM, Bakker NAM, Rolfes AL, Garner H, Boeckx B, Traets JJH, Mandjes IAM, de Maaker M, van Brussel T, Chelushkin M, Champanhet E, Lopez-Yurda M, van de Vijver K, van den Berg JG, Hofland I, Klioueva N, Mann RM, Loo CE, van Duijnhoven FH, Skinner V, Luykx S, Kerver E, Kalashnikova E, van Dongen MGJ, Sonke GS, Linn SC, Blank CU, de Visser KE, Salgado R, Wessels LFA, Drukker CA, Schumacher TN, Horlings HM, Lambrechts D, Kok M. Nederlof I, et al. Among authors: van duijnhoven fh. Nat Med. 2024 Nov;30(11):3223-3235. doi: 10.1038/s41591-024-03249-3. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284953 Free PMC article. Clinical Trial.
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS.
Engelhardt EG, Schmitz RSJM, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager JHE, Griffioen R, Bijker N, Mann RM, Retèl V, van Duijnhoven FH, Wesseling J, Bleiker EMA; Grand Challenge PRECISION Consortium. Engelhardt EG, et al. Among authors: van duijnhoven fh. Breast. 2024 Oct;77:103764. doi: 10.1016/j.breast.2024.103764. Epub 2024 Jul 2. Breast. 2024. PMID: 38970983 Free PMC article.
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer.
van Olmen JP, Schrijver AM, Stokkel MPM, Loo CE, Gunster JLB, Vrancken Peeters MTFD, van Duijnhoven FH, van der Ploeg IMC. van Olmen JP, et al. Among authors: van duijnhoven fh. Breast Cancer Res Treat. 2024 Aug;206(3):585-594. doi: 10.1007/s10549-024-07331-9. Epub 2024 Jun 12. Breast Cancer Res Treat. 2024. PMID: 38864980 Free PMC article.
50 results